Merus NV (MRUS)
59.10
-1.10
(-1.83%)
USD |
NASDAQ |
Jun 28, 16:00
59.06
-0.04
(-0.07%)
After-Hours: 20:00
Merus Accounts Receivable (Quarterly): 58.73M for March 31, 2024
Accounts Receivable (Quarterly) Chart
Historical Accounts Receivable (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 58.73M |
December 31, 2023 | 2.429M |
September 30, 2023 | 3.434M |
June 30, 2023 | 2.836M |
March 31, 2023 | 4.769M |
December 31, 2022 | 4.051M |
September 30, 2022 | 2.628M |
June 30, 2022 | 3.896M |
March 31, 2022 | 2.671M |
December 31, 2021 | 6.306M |
September 30, 2021 | 3.237M |
June 30, 2021 | 3.683M |
March 31, 2021 | 1.925M |
December 31, 2020 | 1.669M |
September 30, 2020 | 2.106M |
June 30, 2020 | 1.951M |
March 31, 2020 | 1.502M |
December 31, 2019 | 2.652M |
September 30, 2019 | 1.764M |
Date | Value |
---|---|
June 30, 2019 | 1.584M |
March 31, 2019 | 3.919M |
December 31, 2018 | 3.351M |
September 30, 2018 | 3.854M |
June 30, 2018 | 2.392M |
March 31, 2018 | 9.838M |
December 31, 2017 | 1.912M |
September 30, 2017 | 3.654M |
June 30, 2017 | 3.335M |
March 31, 2017 | 1.037M |
December 31, 2016 | 0.2156M |
September 30, 2016 | 0.1055M |
June 30, 2016 | 0.1513M |
March 31, 2016 | |
December 31, 2015 | 0.00 |
September 30, 2015 | 0.00 |
June 30, 2015 | |
December 31, 2014 | 0.2092M |
Accounts Receivable Definition
Account used to record sales made "on account", meaning that the company has made a sale but has not collected payment. When company collects cash as payment, the corresponding account receivable is decreased.
Accounts Receivable (Quarterly) Range, Past 5 Years
1.502M
Minimum
Mar 2020
58.73M
Maximum
Mar 2024
5.691M
Average
2.662M
Median
Accounts Receivable (Quarterly) Benchmarks
uniQure NV | 10.72M |
ProQR Therapeutics NV | -- |
argenx SE | -- |
Pharming Group | 38.70M |
Pharvaris NV | -- |